Akèy › Neoplazmi myeloproliferatif › Illinois › Chicago
Etid klinik pou Neoplazmi myeloproliferatif nan Chicago, IL
9 etid pou Neoplazmi myeloproliferatif ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Ap rekriteFaz 2
- University of Chicago Comprehensive Cancer Center, Chicago
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- Northwestern University, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- ak 1 plis
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation
Ap rekriteFaz 1Volontè an sante akeyi
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- Lurie Children's Hospital-Chicago, Chicago
- Northwestern University, Chicago
- University of Illinois, Chicago
- ak 1 plis
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- University of Chicago Medical Center, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Ap rekrite
- University of Chicago Comprehensive Cancer Center, Chicago
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
Ap rekriteEtid obsèvasyon
- MPN Research Foundation, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Chicago
Etid Neoplazmi myeloproliferatif nan lòt vil
- Houston, TX16 etid
- New York City, NY15 etid
- Boston, MA14 etid
- Milwaukee, WI10 etid
- Miami, FL10 etid
- Durham, NC9 etid
- Baldwin Park, CA9 etid
- Seattle, WA9 etid
- Atlanta, GA8 etid
- Tampa, FL8 etid
- Birmingham, AL8 etid
- Columbus, OH8 etid
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete58 etid
- Kansè (tout kalite)51 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Obèsite41 etid
- Kansè poumon41 etid
- Kansè ovè36 etid
- Akidan serebavaskilè34 etid
- Kansè kolorektal33 etid
- Ensifizyans kadyak31 etid
- Sipwa28 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.